glutamatergic dysfunction
-
antipsychotics, biomarkers, brain metabolites, Editor Eimear Foley, first episode psychosis, glutamate, glutamatergic dysfunction, JAMA Psychiatry, mega-analysis, meta-analysis, neuroimaging, personalisation, personalised medicine, prediction, proton magnetic resonance spectroscopy, psychosis, schizophrenia, systematic review, treatment resistance, treatment responseCan brain metabolites predict who responds to antipsychotics?
Antipsychotics are the first choice of treatment for people with schizophrenia or…
